Advocates, Medical Professionals, Patient Organizations, Researchers, Legislative Advocacy, Research & Drug Development, PDF, Research, September 28, 2022 Impact of the Orphan Drug Tax Credit
Medical Professionals, Patient Organizations, Researchers, Regulatory, PDF, Other, FDA’s Flexibility in Regulating Therapies
Advocates, Medical Professionals, Researchers, Legislative Advocacy, Research & Drug Development, PDF, Research, FDA’s Accelerated Approval Pathway: A Rare Disease Perspective
Advocates, Medical Professionals, Patient Organizations, Researchers, Students & Volunteers, Legislative Advocacy, Research & Drug Development, PDF, Research, Orphan Drug Costs and Expenditures
Advocates, Medical Professionals, Researchers, Research & Drug Development, Understanding Rare Disease, PDF, Research, 5 Myths about the Orphan Drug Act
Advocates, Medical Professionals, Patient Organizations, Researchers, Students & Volunteers, Research & Drug Development, PDF, Research, Orphan Drug Trends in the U.S. in 2018
Advocates, Medical Professionals, Patient Organizations, Students & Volunteers, Legislative Advocacy, Research & Drug Development, PDF, Research, Orphan Drugs in the U.S.: Exclusivity, Pricing and Treated Populations
Advocates, Patient & Caregiver, Researchers, Students & Volunteers, COVID-19, PDF, Research, COVID-19 Community Survey Report #1
Advocates, Patient & Caregiver, Researchers, COVID-19, PDF, Education, Research, COVID-19 Community Survey Report #2
